Mirum Pharmaceuticals, Inc. (MIRM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 148.93M | 133.01M | 127.78M | 111.58M | 99.41M | 90.38M | 77.88M | 69.22M | 69.55M | 47.73M | 37.5M | 31.6M | 27.91M | 18.78M | 17.48M | 12.89M | 3.14M | 5M | 11M |
| Revenue Growth % | -100% | 49.81% | 47.17% | 64.09% | 61.2% | 42.93% | 89.37% | 107.68% | 119.07% | 149.24% | 154.13% | 114.46% | 145.1% | 789.29% | 275.6% | 58.95% | - | - | - | - |
| Cost of Goods Sold | 755.11M | 28.34M | 25.54M | 23.42M | 23.02M | 22.78M | 20.81M | 20.23M | 17.83M | 25.02M | 10.23M | 6.81M | 4.98M | 4.49M | 2.93M | 2.52M | 2.42M | 1.9M | 0 | 0 |
| COGS % of Revenue | - | 19.03% | 19.2% | 18.33% | 20.63% | 22.91% | 23.02% | 25.97% | 25.76% | 35.97% | 21.43% | 18.17% | 15.76% | 16.1% | 15.61% | 14.44% | 18.8% | 60.64% | - | - |
| Gross Profit | -755.11M | 120.59M | 107.47M | 104.36M | 88.57M | 76.63M | 69.57M | 57.65M | 51.39M | 44.53M | 37.5M | 30.68M | 26.62M | 23.41M | 15.85M | 14.96M | 10.47M | 1.24M | 5M | 11M |
| Gross Margin % | - | 80.97% | 80.8% | 81.67% | 79.37% | 77.09% | 76.98% | 74.03% | 74.24% | 64.03% | 78.57% | 81.83% | 84.24% | 83.9% | 84.39% | 85.56% | 81.2% | 39.36% | 100% | 100% |
| Gross Profit Growth % | -952.58% | 57.36% | 54.48% | 81.04% | 72.34% | 72.08% | 85.54% | 87.87% | 93.07% | 90.22% | 136.6% | 105.11% | 154.29% | 1795.71% | 216.96% | 36% | - | - | - | - |
| Operating Expenses | 194.24M | 125.23M | 104.87M | 109.35M | 103.75M | 100.86M | 82.25M | 81.88M | 77.86M | 77.12M | 62.65M | 54.96M | 53.77M | 57.57M | 48.73M | 46.4M | 43.2M | 46.81M | 47.82M | 48.4M |
| OpEx % of Revenue | - | 84.09% | 78.84% | 85.58% | 92.98% | 101.45% | 91.01% | 105.14% | 112.48% | 110.88% | 131.26% | 146.57% | 170.16% | 206.31% | 259.48% | 265.39% | 335.12% | 1491.71% | 956.48% | 440.01% |
| Selling, General & Admin | 96.33M | 74.13M | 61.91M | 63.29M | 57.71M | 56.83M | 50.55M | 49.21M | 45.64M | 46.18M | 36.53M | 32.95M | 30.22M | 26.47M | 22.51M | 20.97M | 19.12M | 19.04M | 17.35M | 13.35M |
| SG&A % of Revenue | - | 49.77% | 46.55% | 49.53% | 51.71% | 57.16% | 55.93% | 63.19% | 65.93% | 66.4% | 76.54% | 87.87% | 95.64% | 94.85% | 119.88% | 119.93% | 148.28% | 606.6% | 347.06% | 121.39% |
| Research & Development | 97.91M | 51.11M | 42.96M | 46.07M | 46.04M | 44.03M | 31.71M | 32.67M | 32.22M | 30.93M | 26.12M | 22.01M | 23.55M | 31.11M | 26.22M | 25.43M | 24.09M | 27.77M | 30.47M | 35.05M |
| R&D % of Revenue | - | 34.32% | 32.3% | 36.05% | 41.26% | 44.29% | 35.09% | 41.95% | 46.55% | 44.48% | 54.72% | 58.7% | 74.52% | 111.46% | 139.6% | 145.46% | 186.84% | 885.12% | 609.42% | 318.62% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -789.47M | -4.57M | 2.6M | -4.99M | -15.18M | -24.22M | -12.68M | -24.23M | -26.47M | -32.59M | -25.15M | -24.27M | -27.15M | -34.16M | -32.88M | -31.44M | -32.74M | -45.58M | -42.82M | -37.4M |
| Operating Margin % | - | -3.07% | 1.96% | -3.9% | -13.61% | -24.36% | -14.03% | -31.12% | -38.24% | -46.85% | -52.69% | -64.73% | -85.92% | -122.41% | -175.09% | -179.83% | -253.92% | -1452.36% | -856.48% | -340.01% |
| Operating Income Growth % | -5099.66% | 81.15% | 120.52% | 79.41% | 42.64% | 25.67% | 49.56% | 0.17% | 2.5% | 4.61% | 23.52% | 22.8% | 17.07% | 25.04% | 23.22% | 15.94% | 31.25% | -23.34% | -97.2% | -58.5% |
| EBITDA | -789.47M | 1.51M | 8.66M | 1.07M | -9.13M | -18.17M | -6.63M | -18.38M | -20.8M | -27.09M | -22.49M | -22.94M | -25.81M | -32.83M | -31.79M | -30.74M | -32.29M | -45.14M | -42.65M | -37.23M |
| EBITDA Margin % | - | 1.01% | 6.51% | 0.83% | -8.18% | -18.27% | -7.33% | -23.6% | -30.05% | -38.95% | -47.12% | -61.17% | -81.69% | -117.65% | -169.25% | -175.79% | -250.49% | -1438.43% | -852.92% | -338.42% |
| EBITDA Growth % | -8545.99% | 108.3% | 230.71% | 105.81% | 56.11% | 32.94% | 70.52% | 19.88% | 19.4% | 17.49% | 29.26% | 25.37% | 20.07% | 27.26% | 25.47% | 17.43% | 31.91% | -22.7% | -97.79% | -58.75% |
| D&A (Non-Cash Add-back) | 0 | 6.07M | 6.06M | 6.06M | 6.05M | 6.06M | 6.05M | 5.85M | 5.66M | 5.49M | 2.66M | 1.34M | 1.34M | 1.33M | 1.1M | 705K | 443K | 437K | 178K | 175K |
| EBIT | 0 | -1.36M | 3M | -1.87M | -10.05M | -20.79M | -10.3M | -20.43M | -21.08M | -31.87M | -19.77M | -70M | -25.69M | -31.93M | -31.72M | -29.62M | -32.82M | 61.32M | -41.43M | -39.11M |
| Net Interest Income | 0 | -178K | -355K | -556K | -573K | -375K | -117K | -83K | 56K | 212K | 487K | -99K | -1.97M | -2.22M | -2.62M | -3.58M | -3.71M | -3.7M | -5.59M | -4.7M |
| Interest Income | 3.4M | 3.42M | 3.25M | 3.03M | 3.02M | 3.2M | 3.47M | 3.49M | 3.63M | 3.77M | 4.06M | 3.63M | 2.27M | 2.14M | 1.35M | 293K | 69K | 65K | 72K | 80K |
| Interest Expense | -3.62M | 3.6M | 3.61M | 3.59M | 3.6M | 3.58M | 3.59M | 3.57M | 3.58M | 3.56M | 3.57M | 3.73M | 4.24M | 4.36M | 3.97M | 3.88M | 3.77M | 3.77M | 5.67M | 4.78M |
| Other Income/Expense | -215K | -396K | 40K | -470K | 1.53M | -144K | -1.2M | 229K | 1.81M | -2.85M | 1.81M | -49.45M | -2.78M | -2.13M | -2.81M | -2.05M | -3.86M | 103.13M | -4.28M | -6.48M |
| Pretax Income | -789.68M | -4.96M | 2.64M | -5.46M | -13.65M | -24.37M | -13.89M | -24M | -24.66M | -35.43M | -23.34M | -73.72M | -29.93M | -36.29M | -35.69M | -33.49M | -36.59M | 57.56M | -47.1M | -43.88M |
| Pretax Margin % | - | -3.33% | 1.99% | -4.27% | -12.23% | -24.51% | -15.37% | -30.82% | -35.62% | -50.94% | -48.9% | -196.61% | -94.72% | -130.05% | -190.06% | -191.56% | -283.86% | 1834.23% | -941.98% | -398.94% |
| Income Tax | 475K | 767K | -262K | 402K | 1.03M | -576K | 347K | 635K | 624K | 225K | 249K | 316K | 201K | 140K | 13K | -6.57M | 11K | 12K | 9K | 11K |
| Effective Tax Rate % | -0.06% | -15.45% | -9.91% | -7.36% | -7.54% | 2.36% | -2.5% | -2.65% | -2.53% | -0.63% | -1.07% | -0.43% | -0.67% | -0.39% | -0.04% | 19.62% | -0.03% | 0.02% | -0.02% | -0.03% |
| Net Income | -790.15M | -5.73M | 2.9M | -5.86M | -14.68M | -23.79M | -14.23M | -24.64M | -25.28M | -35.66M | -23.59M | -74.04M | -30.13M | -36.43M | -35.71M | -26.92M | -36.61M | 57.55M | -47.11M | -43.89M |
| Net Margin % | - | -3.85% | 2.18% | -4.59% | -13.15% | -23.93% | -15.75% | -31.64% | -36.52% | -51.27% | -49.42% | -197.45% | -95.35% | -130.55% | -190.13% | -153.98% | -283.94% | 1833.84% | -942.16% | -399.04% |
| Net Income Growth % | -5283.63% | 75.91% | 120.41% | 76.21% | 41.94% | 33.28% | 39.65% | 66.72% | 16.1% | 2.12% | 33.94% | -175.01% | 17.69% | -163.31% | 24.2% | 38.67% | 27.56% | 254.68% | -119.05% | -88.78% |
| Net Income (Continuing) | -790.15M | -5.73M | 2.9M | -5.86M | -14.68M | -23.79M | -14.23M | -24.64M | -25.28M | -35.66M | -23.59M | -74.04M | -30.13M | -36.43M | -35.71M | -26.92M | -36.61M | 57.55M | -47.11M | -43.89M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -13.43 | -0.12 | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 | -0.80 | -0.97 | -1.02 | -0.84 | -1.17 | 1.88 | -1.55 | -1.45 |
| EPS Growth % | -4376.67% | 75.51% | 117% | 76.92% | 44.44% | 30.99% | 47.37% | 73.2% | 32.5% | 26.8% | 44.12% | -130.95% | 31.62% | -151.6% | 34.19% | 42.07% | 30.36% | 231.47% | -80.23% | -55.91% |
| EPS (Basic) | -13.43 | -0.12 | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 | -0.80 | -0.99 | -1.02 | -0.84 | -1.17 | 1.88 | -1.55 | -1.45 |
| Diluted Shares Outstanding | 58.85M | 50.2M | 56.99M | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 37.52M | 34.93M | 32.18M | 31.3M | 30.58M | 30.37M | 30.27M |
| Basic Shares Outstanding | 58.85M | 50.2M | 58.1M | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 36.96M | 34.93M | 32.16M | 31.3M | 30.32M | 30.37M | 30.27M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |